Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov 22;7(47):76704-76712.
doi: 10.18632/oncotarget.12501.

Impact of HPV infection on oral squamous cell carcinoma

Affiliations

Impact of HPV infection on oral squamous cell carcinoma

Carolin Götz et al. Oncotarget. .

Abstract

Background: Head and neck squamous cell carcinomas (HNSCC) are often divided by their aetiology. Noxae associated collectives are compared with the human papilloma virus (HPV)-associated group, whereas different localisations of oral (OSCC) and oropharyngeal (OPSCC) squamous cell carcinomas are mostly discussed as one single group. Our aim was to show that classification by aetiology is not appropriate for OSCC.

Results: HPV DNA was detected by PCR in 7 (3.47%) patients, and we identified 12 (5.94%) positive (+) cases by p16INK4a immunostaining. Only 4 (1.98%) of the p16INK4a+ cases were + for HPV using PCR. Our homogenous collective of OSCC allowed us to compare HPV+ and HPV negative (-) patients without creating bias for tumour localisation, age, gender or tumour stage.

Materials and methods: After testing OSCC samples for HPV positivity, we compared the results of two commonly used HPV detection methods, p16INK4a immunostaining and HPV DNA-related PCR, on 202 OSCC patients. HPV subtypes were determined with an HPV LCD Array Kit. Clinicopathological features of the patients were analysed, and the disease specific survival rates (DSS) for HPV+ and HPV- patients were obtained.

Conclusions: p16INK4a immunostaining is a not a reliable HPV detection method for OSCC. Positive p16INK4a immunostaining did not agree with + results from PCR of HPV DNA. Furthermore, the influence of HPV-related oncogenic transformation in OSCC is overestimated. The significance of HPV infection remains clinically unclear, and its influence on survival rates is not relevant to OSCC cases.

Keywords: HPV; head and neck cancer; oral squamous cell carcinoma; p16ink4a.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

None.

Figures

Figure 1
Figure 1. Interaction modell of p16INK4a in HPV negative cases: Tumoursuppressor Retinoblastoma gene (Rb) is inhibiting transcription factor E2F
As a consequence, p16INK4a is not affectd by E2F.
Figure 2
Figure 2. Interaction modell of p16INK4a in HPV positive cases: The HPV associated oncoprotein E7 acts in a double way: Rb is inhibited and E2F is promoted
As a result E2F is upregulated and p16INK4a is overexpressed.
Figure 3
Figure 3. Immunohistochemistry of p16INK4a of two OSCC samples, on the left side p16INK4a + and on the right side p16INK4a
Figure 4
Figure 4
(1) PCR results for detecting HPV positive (H+) and negative cases (H−). A HPV positive cervix carcinoma was used as a positive control (+C). (2) A control PCR was performed in every case to detect sufficient amounts of DNA. If DNA amounts were insufficient as shown in row 2, DNA was newly extracted from FFPE. Otherwise a clear signal was seen in the specific row (+).

References

    1. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35. - PMC - PubMed
    1. Annertz K, Rosenquist K, Andersson G, Jacobsson H, Hansson BG, Wennerberg J. High-risk HPV and survival in patients with oral and oropharyngeal squamous cell carcinoma - 5-year follow up of a population-based study. Acta Otolaryngol. 2014;134:843–51. - PubMed
    1. Argiris A. EGFR inhibition for recurrent or metastatic HNSCC. Lancet Oncol. 2015;16:488–9. - PubMed
    1. Benson E, LI R, Eisele D, Fakhry C. The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol. 2014;50:565–74. - PMC - PubMed
    1. Coppock JD, Vermeer PD, Vermeer DW, Lee KM, Miskimins WK, Spanos WC, LEE JH. mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC. Oncotarget. 2016;7:24228–41. doi: 10.18632/oncotarget.8286. - DOI - PMC - PubMed

MeSH terms

Substances